BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11241793)

  • 1. Lack of BCL10 mutations in multiple myeloma and plasma cell leukemia.
    Shih LY; Fu JF; Shurtleff SA; Morris SW; Downing JR
    Genes Chromosomes Cancer; 2001 Apr; 30(4):402-6. PubMed ID: 11241793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of Bcl10 gene mutations in laryngeal squamous cell carcinoma.
    Ronchetti D; Intini D; Pruneri G; Neri A; Pignataro L
    J Laryngol Otol; 2002 Aug; 116(8):610-2. PubMed ID: 12389689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: report of 46 cases.
    Jihua C; Xisheng L; Shengli C; Zongxian C; Guang C; Ruyu D
    Hum Mutat; 2000 May; 15(5):482-3. PubMed ID: 10790217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
    Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
    J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of BCL10 mRNA mutation in lymphold malignancies.
    Kawano T; Iwase S; Nakayama R; Horiguchi-Yamada J; Kobayashi M; Yamada H
    Anticancer Res; 2002; 22(1A):305-9. PubMed ID: 12017308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Bcl10 mutations in malignant cartilaginous tumors.
    Park YK; Park HR; Kim YW; Chi SG; Unni KK
    Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.
    Bezieau S; Devilder MC; Avet-Loiseau H; Mellerin MP; Puthier D; Pennarun E; Rapp MJ; Harousseau JL; Moisan JP; Bataille R
    Hum Mutat; 2001 Sep; 18(3):212-24. PubMed ID: 11524732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in Bcl10 are very rare in colorectal cancer.
    Stone JG; Rowan AJ; Tomlinson IP; Houlston RS
    Br J Cancer; 1999 Jul; 80(10):1569-70. PubMed ID: 10408399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the BCL10 gene in childhood solid malignancies.
    Miao J; Kusafuka T; Udatsu Y; Okada A
    Med Pediatr Oncol; 2002 Dec; 39(6):543-6. PubMed ID: 12376974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.
    Gill S; Broni J; Jefferies S; Osin P; Kovacs G; Maitland NJ; Eeles R; Edwards SM; Dyer MJ; Willis TG; Cooper CS
    Br J Cancer; 1999 Jul; 80(10):1565-8. PubMed ID: 10408398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
    Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
    Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines.
    van Schothorst EM; Mohkamsing S; van Gurp RJ; Oosterhuis JW; van der Saag PT; Looijenga LH
    Br J Cancer; 1999 Jul; 80(10):1571-4. PubMed ID: 10408400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of Bcl10 gene mutations in Ewing's sarcomas.
    Park YK; Chi SG; Unni KK
    Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration].
    Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY
    Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.
    Martín P; Santón A; García-Cosío M; Bellas C
    Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.
    Takahashi H; Hosokawa Y; Suzuki R; Morishima Y; Nakamura S; Seto M
    Jpn J Cancer Res; 1999 Dec; 90(12):1316-20. PubMed ID: 10665648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL10 gene mutations rarely occur in lymphoid malignancies.
    Luminari S; Intini D; Baldini L; Berti E; Bertoni F; Zucca E; Cro L; Maiolo AT; Cavalli F; Neri A
    Leukemia; 2000 May; 14(5):905-8. PubMed ID: 10803524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of mutations in exon 7 of p53 from fresh tumor samples by single-strand conformation polymorphism and direct DNA sequencing].
    Zhang X; Fu Y; Liu S; Liang C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):142-5. PubMed ID: 12761985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.